Newsfiscal.ai
Rallybio Stockholders Approve Merger with Avenzo Therapeutics
· Published
Article summary
Rallybio stockholders voted to approve key proposals related to the company's pending merger with Avenzo Therapeutics, including share issuance and corporate name change.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…